+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nephrostomy Devices Market (2022-2027) by Product, End User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 194 Pages
  • September 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5669464
UP TO OFF until Dec 31st 2023

Growing cases of lifestyle-related disorders are likely to contribute to the market development. Improving healthcare infrastructure in the emerging economies is also influencing the market

The Global Nephrostomy Devices Market is estimated to be USD 972.2 Mn in 2022 and is expected to reach USD 1489 Mn by 2027, growing at a CAGR of 8.9%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Market Segmentations

The Global Nephrostomy Devices Market is segmented based on Product, End User, and Geography.
  • By Product, the market is classified into Guidewires, Drainage Tubes, Nephrostomy Catheters and Sheath Dilators.
  • By End User, the market is classified into Hospitals, Emergency Clinics and Ambulatory Surgical Centers.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are AngioDynamics, Inc., Argon Medical, B. Braun Melsungen Ag, Becton, Dickinson, and Company, Boston Scientific Corp., Cardinal Health, Inc., Coloplast A/S, Copenhagen MedLab, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Nephrostomy Devices Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Nephrostomy Devices Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Nephrostomy Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Nephrostomy Devices Market

What is the estimated value of the Global Nephrostomy Devices Market?

The Global Nephrostomy Devices Market was estimated to be valued at $972.2 Million in 2022.

What is the growth rate of the Global Nephrostomy Devices Market?

The growth rate of the Global Nephrostomy Devices Market is 8.9%, with an estimated value of $1489 Million by 2027.

What is the forecasted size of the Global Nephrostomy Devices Market?

The Global Nephrostomy Devices Market is estimated to be worth $1489 Million by 2027.

Who are the key companies in the Global Nephrostomy Devices Market?

Key companies in the Global Nephrostomy Devices Market include AngioDynamics, Inc., Argon Medical, B. Braun Melsungen Ag, Becton, Dickinson, and Company, Boston Scientific Corp., Cardinal Health, Inc., Coloplast A/S, Copenhagen MedLab, Cook Group, Inc. and Envaste, Ltd..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Cases of Kidney Stone Disorders
4.1.2 Rise in Demand for Minimally Invasive Surgeries
4.1.3 Increasing Awareness about the Nephrostomy Devices
4.2 Restraints
4.2.1 Risk Associated with Nephrostomy Procedure
4.2.2 Improving Healthcare Infrastructure in Emerging Economies
4.2.3 Rising Number of Hydronephroses
4.3 Challenges
4.3.1 Alternative Procedures Such as Ureteral Stenting
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global Nephrostomy Devices Market, By Product
6.1 Introduction
6.2 Guidewires
6.3 Drainage Tubes
6.4 Nephrostomy Catheters
6.5 Sheath Dilators
7 Global Nephrostomy Devices Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Emergency Clinics
7.4 Ambulatory Surgical Centers
8 Americas’ Nephrostomy Devices Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Nephrostomy Devices Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Nephrostomy Devices Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Nephrostomy Devices Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 IGR Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 AngioDynamics, Inc.
13.2 Argon Medical
13.3 B. Braun Melsungen Ag
13.4 Becton, Dickinson, and Company
13.5 Boston Scientific Corp.
13.6 Cardinal Health, Inc.
13.7 Coloplast A/S
13.8 Copenhagen MedLab
13.9 Cook Group, Inc.
13.10 Envaste, Ltd.
13.11 Medi-Globe GmbH
13.12 Meditech Devices Pvt. Ltd.
13.13 Olympus Corp.
13.15 Teleflex, Inc.
13.16 Uresil, LLC
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • AngioDynamics, Inc.
  • Argon Medical
  • B. Braun Melsungen Ag
  • Becton, Dickinson, and Company
  • Boston Scientific Corp.
  • Cardinal Health, Inc.
  • Coloplast A/S
  • Copenhagen MedLab
  • Cook Group, Inc.
  • Envaste, Ltd.
  • Medi-Globe GmbH
  • Meditech Devices Pvt. Ltd.
  • Olympus Corp.
  • Teleflex, Inc.
  • Uresil, LLC